# Connected Packaging for Medical Cannabis (THC) | Patient PIL, Batch COA & Yellow Card | SmartLinks

Patient-only connected packaging for prescription cannabis (CBPMs). Digital PIL, batch and strain COA, dosing titration, Yellow Card reporting and clinic-mediated refill — MHRA Blue Guide compliant, no consumer advertising.

Canonical URL: https://www.smartlinks.app/solutions/health-beauty/medical-cannabis

SmartLinks™ turns every prescription cannabis pack into a patient-only portal — digital PIL, batch and strain COA, dosing titration, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.

# Smarter Packaging for Medical Cannabis

SmartLinks™ turns every prescription cannabis pack into a patient-only portal — digital PIL, batch and strain COA, dosing titration, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.

[Book a walkthrough](https://calendly.com/prove-anything/prove-anything-discovery-meeting) · [Explore All Categories](/solutions/health-beauty)
## Connected Packaging Features for Medical Cannabis

Everything You Need, Built In — Discover how SmartLinks™ technology enhances every aspect of your products

- **Digital Patient Information Leaflet**
- **Batch & Strain COA**
- **Dosing Titration Guidance**
- **Yellow Card ADR Reporting**
- **Clinic-Mediated Refill Request**
- **Tamper-Evidence & Serial Auth**

## Patient Engagement & Adherence — Not Consumer Marketing

Medical cannabis is a prescription-only medicine. UK advertising to the public is prohibited under the [Human Medicines Regulations 2012](https://www.legislation.gov.uk/uksi/2012/1916/contents) and the [MHRA Blue Guide](https://www.gov.uk/government/publications/blue-guide-advertising-and-promoting-medicines); the EU equivalent is Directive 2001/83/EC Title VIII. SmartLinks™ deliberately replaces consumer loyalty and discount mechanics with clinic-authorised patient-support tools.
## How It Works

1. **Serialise Every GMP Batch** — Add a GS1 Digital Link QR code with unique serial identifiers per pack — aligned with GMP batch records, cold-chain data and specials-route requirements.
2. **Patient Scans Post-Dispense** — After the pack is dispensed, a scan opens the patient-only portal — PIL, batch COA, dosing, ADR reporting and clinic refill — with prescription verification recommended before commerce actions.
3. **Support Adherence, Safety & Recall** — Batch and serial data power adherence support, adverse-event capture, tamper-evidence and rapid recall — a full patient-safety loop attached to every unit.

## Industry Use Cases

- **Medical Cannabis Flower**
- **Oral Oils & Sublingual Sprays**
- **Vape Cartridges (Medical)**
- **Capsules & Softgels**
- **Clinics & Pharmacies**
- **Recall & Pharmacovigilance**
### FAQ

**Can you advertise medical cannabis to the public through a QR portal?**

No. Cannabis-based products for medicinal use (CBPMs) are prescription-only medicines under the UK's specials route, and advertising POMs to the general public is prohibited by regulation 279 of the [Human Medicines Regulations 2012](https://www.legislation.gov.uk/uksi/2012/1916/contents) and the [MHRA Blue Guide](https://www.gov.uk/government/publications/blue-guide-advertising-and-promoting-medicines). The equivalent EU rule is Article 88 of [Directive 2001/83/EC](https://eur-lex.europa.eu/eli/dir/2001/83/oj). SmartLinks builds the portal as patient-only content — PIL, batch, dosing, safety, refill — never as consumer marketing.

**Why is there no loyalty, discount or cross-sell layer?**

Consumer-style engagement — points, referral bounties, discount codes, cross-sell — is inappropriate for a scheduled POM and can be treated as unlawful promotion or inducement. The medical cannabis flow deliberately replaces those mechanics with clinic-mediated refill, adherence diary and prescriber-authored education. The [CBD page](/solutions/health-beauty/cbd) is where consumer mechanics live for the non-POM cannabinoid range.

**Is a digital PIL actually allowed?**

Yes. The [MHRA best-practice guidance on patient information leaflets](https://www.gov.uk/government/publications/best-practice-guidance-on-patient-information-leaflets) supports digital PIL alongside paper, and the [EMA electronic product information (ePI) framework](https://www.ema.europa.eu/en/human-regulatory-overview/marketing-authorisation/product-information-requirements) is heading the same way for centrally-authorised products. SmartLinks routes the digital PIL for the exact batch and product a patient scans.

**How is adverse-event reporting handled?**

The portal offers a one-tap route to the [MHRA Yellow Card scheme](https://yellowcard.mhra.gov.uk/), prefilled with the product name, batch and serial from the scan — reducing friction for patients and prescribers reporting suspected adverse reactions.

**How does refill work without a consumer checkout?**

Refill requests are routed to the patient's prescribing clinic (not a shop cart), with prescription and identity verification before any dispensing conversation. The pack triggers the request; the clinic remains the authoriser — keeping the flow inside the specials-route and prescriber-of-record framework.
## Ready to Give Prescription Cannabis a Patient-Only Portal?

Book a walkthrough to see SmartLinks across your CBPM range — digital PIL, batch COA, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.

[Book a walkthrough](https://calendly.com/prove-anything/prove-anything-discovery-meeting) · [Back to Health & Beauty](/solutions/health-beauty)

---
_Generated from SmartLinks solutions registry._